Health values of patients infected with human immunodeficiency virus. Relationship to mental health and physical functioning.

To assess the health values of patients infected with human immunodeficiency virus (HIV) and examine the relationships between their health values and health status at two points in time, the authors sought to determine whether patients' physical and mental health statuses were good predictors of how they valued their current state of health. One hundred thirty-nine patients with various stages of HIV infection were interviewed in a prospective cohort study based in a primary care practice of a community-based teaching hospital. Patients were interviewed twice at 6-month intervals using three health value measures--the time trade off, rating scale, and Quality of Well-being Scale--and three health status measures: the 18-item Mental Health Inventory, the Dyspnea-Fatigue Index, and the Medical Outcomes Study SF-36 Health Survey. The health status of HIV-infected patients was compromised and, with the exception of mental health, generally was worse among patients with more advanced HIV-infection. Rating scale and Quality of Well-being Scale scores were related inversely to disease stage, but time-trade off scores generally were higher regardless of disease stage. Health value measures showed moderate relationships with measures of physical functioning (r = 0.34-0.68) but only a fair relationship with mental health (r = 0.00-0.48). The health status of HIV-infected patients who remained asymptomatic or remained symptomatic but without developing acquired immunodeficiency syndrome (AIDS) changed little over 6 months, whereas the health status of patients with AIDS and of patients manifesting progression of HIV-infection deteriorated over time. In contrast, health values, particularly time-tradeoff scores, remained stable even in the face of changes in health status and disease progression. With the exception of mental health, the impact of HIV infection on health status tends to parallel the clinical stage of disease. Health values of HIV-infected patients, however, generally are high and correlate better with physical functioning than with mental health.

[1]  L. Goldman,et al.  Health Values of the Seriously Ill , 1996, Annals of Internal Medicine.

[2]  F. J. Fowler,et al.  The Role of Reluctance to Give Up life in the Measurement of the Values of Health states , 1995, Medical decision making : an international journal of the Society for Medical Decision Making.

[3]  D A Revicki,et al.  Change in clinical status, health status, and health utility outcomes in HIV-infected patients. , 1995, Medical care.

[4]  P. Volberding,et al.  Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. The AIDS Clinical Trials Group. , 1994, The New England journal of medicine.

[5]  M H Liang,et al.  Stability and responsiveness of utility measures. , 1994, Medical care.

[6]  C. Sherbourne,et al.  The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. , 1994 .

[7]  Mph Joel Tsevat Methods for assessing health-related quality of life in HIV-infected patients , 1994 .

[8]  A. Wu,et al.  Assessment of quality of life in HIV disease , 1994 .

[9]  D. Lamping Methods for measuring outcomes to evaluate interventions to improve health-related quality of life in HIV infection , 1994 .

[10]  H. Rubin,et al.  Approaches to health status assessment in hiv disease overview of the conference , 1994 .

[11]  P D Cleary,et al.  Health-Related Quality of Life in Persons with Acquired Immune Deficiency Syndrome , 1993, Medical care.

[12]  R. Klein,et al.  The Beaver Dam Health Outcomes study , 1993, Medical decision making : an international journal of the Society for Medical Decision Making.

[13]  L Goldman,et al.  Stability of Time-tradeoff Utilities in Survivors of Myocardial Infarction , 1993, Medical decision making : an international journal of the Society for Medical Decision Making.

[14]  J F Fries,et al.  Health status among persons infected with human immunodeficiency virus. A community-based study. , 1993, Medical care.

[15]  C. McHorney,et al.  The MOS 36‐Item Short‐Form Health Survey (SF‐36): II. Psychometric and Clinical Tests of Validity in Measuring Physical and Mental Health Constructs , 1993, Medical care.

[16]  D. Patrick,et al.  Health Status and Health Policy: Quality of Life in Health Care Evaluation and Resource Allocation , 1993 .

[17]  H. Llewellyn-Thomas,et al.  Cancer Patients' Evaluations of Their Current Health State , 1992, Medical decision making : an international journal of the Society for Medical Decision Making.

[18]  C. Sherbourne,et al.  The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .

[19]  D A Redelmeier,et al.  Variability among methods to assess patients' well-being and consequent effect on a cost-effectiveness analysis. , 1992, Journal of clinical epidemiology.

[20]  D A Revicki,et al.  Relationship between health utility and psychometric health status measures. , 1992, Medical care.

[21]  G L Drusano,et al.  A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection. Results of the Veterans Affairs Cooperative Study. , 1992, The New England journal of medicine.

[22]  J. Fleishman,et al.  Quality of Life in Persons with Human Immunodeficiency Virus Infection: Measurement by the Medical Outcomes Study Instrument , 1992, Annals of Internal Medicine.

[23]  David Feeny,et al.  Guide to design and development of health-state utility instrumentation , 1992 .

[24]  L. Goldman,et al.  Functional status versus utilities in survivors of myocardial infarction. , 1991, Medical care.

[25]  J. Rabkin,et al.  The concurrent validity of items in the Quality-of-Life Index in a cohort of HIV-positive and HIV-negative gay men. , 1991, Controlled clinical trials.

[26]  H. Rubin,et al.  A Health Status Questionnaire Using 30 Items From The Medical Outcomes Study: Preliminary Validation in Persons With Early HIV Infection , 1991, Medical care.

[27]  A. Ciampi,et al.  Benign and Malignant Breast Disease , 1991, Medical decision making : an international journal of the Society for Medical Decision Making.

[28]  P. Bacchetti,et al.  Results of a one year longitudinal study of HIV antibody test notification from the San Francisco General Hospital cohort. , 1991, Journal of acquired immune deficiency syndromes.

[29]  K. A. Johnston,et al.  Quality of life bibliography and indexes. , 1990, Medical care.

[30]  J. Morrow,et al.  Quality of Life as a Function Of HIV Classification , 1990, Nursing research.

[31]  L. A. Kurdek,et al.  The Nature and Correlates of Psychological Adjustment in Gay Men with AIDS‐Related Conditions1 , 1990 .

[32]  Douglas D. Richman,et al.  The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection a double-blind, placebo-controlled trial , 1990 .

[33]  S W Lagakos,et al.  Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection , 1990 .

[34]  D. Matchar,et al.  Assessing quality of life and preferences in the seriously ill using utility theory. , 1990, Journal of clinical epidemiology.

[35]  L. Goldman,et al.  Patient characteristics in SUPPORT: activity status and cognitive function. , 1990, Journal of clinical epidemiology.

[36]  I Grant,et al.  Quality of life in a placebo-controlled trial of zidovudine in patients with AIDS and AIDS-related complex. , 1990, Journal of acquired immune deficiency syndromes.

[37]  G. Devins,et al.  Psychosocial distress and well-being among gay and bisexual men with human immunodeficiency virus infection. , 1989, The American journal of psychiatry.

[38]  M. Weinstein,et al.  A Comparison of Three Psychiatric Screening Tests Using Receiver Operating Characteristic (ROC) Analysis , 1989, Medical care.

[39]  D. Richman,et al.  Prevalence of psychiatric disorders among men infected with human immunodeficiency virus. A controlled study. , 1988, Archives of general psychiatry.

[40]  M A Fischl,et al.  The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. , 1987, The New England journal of medicine.

[41]  M A Fischl,et al.  The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. , 1987, The New England journal of medicine.

[42]  G. Torrance,et al.  Measurement of quality of life in end-stage renal disease: the time trade-off approach. , 1987, Clinical and investigative medicine. Medecine clinique et experimentale.

[43]  Selwyn Pa AIDS: what is now known. IV. Psychosocial aspects, treatment prospects. , 1986 .

[44]  Selwyn,et al.  AIDS: What Is Now Known , 1986 .

[45]  G. Torrance Measurement of health state utilities for economic appraisal. , 1986, Journal of health economics.

[46]  C. Wells,et al.  The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. , 1984, Chest.

[47]  J. Ware,et al.  The structure of psychological distress and well-being in general populations , 1983 .

[48]  Joseph S. Pliskin,et al.  Utility Functions for Life Years and Health Status , 1980, Oper. Res..

[49]  R M Kaplan,et al.  Health status: types of validity and the index of well-being. , 1976, Health services research.

[50]  G W Torrance,et al.  A utility maximization model for evaluation of health care programs. , 1972, Health services research.